171 – 180 of 460
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Intra-individual short-term variability of prostate-specific antigen and other kallikrein markers in a serial collection of blood from men under evaluation for prostate cancer.
(
- Contribution to journal › Article
-
Mark
TMPRSS2-ERG Status in circulating tumor cells as a predictive biomarker of sensitivity in castration-resistant prostate cancer patients treated with abiraterone acetate
(
- Contribution to journal › Article
-
Mark
Evaluation of prediagnostic prostate-specific antigen dynamics as predictors of death from prostate cancer in patients treated conservatively
(
- Contribution to journal › Article
-
Mark
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection
(
- Contribution to journal › Article
-
Mark
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer : Preliminary analysis of the results of the IMPACT study
(
- Contribution to journal › Article
-
Mark
Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening
(
- Contribution to journal › Article
-
Mark
Detection of prostate cancer : PSA
2011) p.283-334(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Measuring density and compressibility of white blood cells and prostate cancer cells by microchannel acoustophoresis
2011) 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011 In 15th International Conference on Miniaturized Systems for Chemistry and Life Sciences 2011, MicroTAS 2011 1. p.127-129(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2010
-
Mark
Prostate Specific Antigen Velocity Does Not Aid Prostate Cancer Detection in Men With Prior Negative Biopsy
(
- Contribution to journal › Article
-
Mark
A Common Prostate Cancer Risk Variant 5 ' of Microseminoprotein-beta (MSMB) Is a Strong Predictor of Circulating beta-Microseminoprotein (MSP) Levels in Multiple Populations
(
- Contribution to journal › Article